EP2915129A1 - Wireless communication authentication for medical monitoring device - Google Patents
Wireless communication authentication for medical monitoring deviceInfo
- Publication number
- EP2915129A1 EP2915129A1 EP13852024.2A EP13852024A EP2915129A1 EP 2915129 A1 EP2915129 A1 EP 2915129A1 EP 13852024 A EP13852024 A EP 13852024A EP 2915129 A1 EP2915129 A1 EP 2915129A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- pairing
- processor
- external device
- unauthenticated
- authenticated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000004891 communication Methods 0.000 title claims abstract description 59
- 238000012806 monitoring device Methods 0.000 title claims description 21
- 239000012491 analyte Substances 0.000 claims abstract description 65
- 238000000034 method Methods 0.000 claims abstract description 65
- 230000004044 response Effects 0.000 claims abstract description 7
- 230000000977 initiatory effect Effects 0.000 claims abstract description 3
- 238000012790 confirmation Methods 0.000 claims description 3
- 230000036541 health Effects 0.000 description 56
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 36
- 239000008103 glucose Substances 0.000 description 36
- 238000012360 testing method Methods 0.000 description 34
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- 238000013500 data storage Methods 0.000 description 12
- 239000012530 fluid Substances 0.000 description 9
- 230000005540 biological transmission Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000005236 sound signal Effects 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 229910001416 lithium ion Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- QELJHCBNGDEXLD-UHFFFAOYSA-N nickel zinc Chemical compound [Ni].[Zn] QELJHCBNGDEXLD-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- OJIJEKBXJYRIBZ-UHFFFAOYSA-N cadmium nickel Chemical compound [Ni].[Cd] OJIJEKBXJYRIBZ-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- -1 nickel metal hydride Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
- G01N33/48792—Data management, e.g. communication with processing unit
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
- G06F21/30—Authentication, i.e. establishing the identity or authorisation of security principals
- G06F21/44—Program or device authentication
- G06F21/445—Program or device authentication by mutual authentication, e.g. between devices or programs
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04W—WIRELESS COMMUNICATION NETWORKS
- H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
- H04W4/80—Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B5/00—Near-field transmission systems, e.g. inductive or capacitive transmission systems
- H04B5/70—Near-field transmission systems, e.g. inductive or capacitive transmission systems specially adapted for specific purposes
- H04B5/73—Near-field transmission systems, e.g. inductive or capacitive transmission systems specially adapted for specific purposes for taking measurements, e.g. using sensing coils
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B5/00—Near-field transmission systems, e.g. inductive or capacitive transmission systems
- H04B5/70—Near-field transmission systems, e.g. inductive or capacitive transmission systems specially adapted for specific purposes
- H04B5/77—Near-field transmission systems, e.g. inductive or capacitive transmission systems specially adapted for specific purposes for interrogation
Definitions
- the embodiments herein relate in general to a device and method for determining and reporting glucose readings in wireless personal area networks for diabetics.
- hand-held meters can advantageously be manufactured to include wireless communication capability.
- Such capability can assist the user in downloading data to a home computer or to a handheld computing device, for example. This minimizes the need for the user to write down data and transfer it later to an electronic record.
- the present disclosure provides a device, including a housing, a processor coupled to the housing, a low energy wireless transmission unit, and a memory device coupled to the housing and the processor, wherein the memory device includes instructions which, when executed by the processor, cause the processor to detect an analyte sample; determine an analyte concentration associated with the detected analyte sample; generate an unauthenticated pairing between the device and an external device by causing the wireless transceiver to initiate a pairing procedure of the wireless protocol stack with the external device, and on a condition that the wireless protocol stack issues a pairing message, suppressing the pairing message, prevent communication based on the unauthenticated pairing between the device and the external device; generate an authenticated pairing based on the unauthenticated pairing by displaying a pairing authentication message, and in response to user input indicating that the unauthenticated pairing is an authenticated pairing; converting the unauthenticated pairing to an authenticated pairing; and cause the wireless transceiver to transmit an indication of the analyte concentration to the external
- the present disclosure provides a method including detecting an analyte sample; determining an analyte concentration associated with the detected analyte sample; generating an unauthenticated pairing with an external device by initiating a pairing procedure of a wireless protocol stack with the external device, and on a condition that the wireless protocol stack issues a pairing message, suppressing the pairing message; preventing communication based on the unauthenticated pairing with the external device; generating an authenticated pairing based on the unauthenticated pairing by displaying a pairing authentication message, and in response to user input indicating that the unauthenticated pairing is an authenticated pairing, converting the unauthenticated pairing to an authenticated pairing; and transmitting an indication of the analyte concentration to the external device.
- FIG. 1 is a schematic view showing typical data signal flow between devices of a wireless system constructed according to one embodiment of the present invention.
- FIG. 2 is a schematic view showing the client device of Fig. 1.
- FIG. 3 is a schematic view showing the server device of Fig. 1.
- FIG. 4 is a pictorial view showing a typical client device and typical server devices.
- FIG. 5 is a perspective view showing an integrated device of an alternative embodiment.
- FIG. 6 is a diagram of a health monitor device in accordance with some embodiments of this disclosure.
- Fig. 7 is a diagram of an example of wireless communication authentication for medical monitoring device in accordance with some embodiments of this disclosure.
- Test strip 101 electrically communicates with client device 102, which wirelessly communicates with server device 104, such as by two- way radio frequency (RF) contact, infrared (IR) contact, Bluetooth® contact or other known wireless means 103.
- server device 104 can also communicate with other devices such as data processing terminal 105 by direct electronic contact, via RF, IR, Bluetooth® or other wireless means.
- Test strip 101 is a commonly known electrochemical analyte test strip, such as a blood glucose test strip as described in U.S. patent application number 09/434,026 filed November 4, 1999 entitled “Small Volume In Vitro Analyte Sensor and Methods", incorporated herein by reference. It is mechanically received in a test strip port of a client device 102, similar to a commonly known hand-held blood glucose meter as described in the aforementioned patent application.
- client device 102 is constructed without a user interface or display to keep the size and cost of device 102 to a minimum.
- Client device 102 can take the form of a highlighter or easel- sized pen, as shown in Fig. 4, and can be powered by a single AA or AAA size battery.
- Client device 102 wirelessly communicates with server device 104, preferably using a common standard such as 802.11 or Bluetooth® RF protocol, or an IrDA infrared protocol.
- Server device 104 can be another portable device, such as a Personal Digital Assistant (PDA) or notebook computer, or a larger device such as a desktop computer, appliance, etc. as shown by the examples in Fig. 4.
- PDA Personal Digital Assistant
- server device 104 does have a display, such as a liquid crystal display (LCD), as well as an input device, such as buttons, a keyboard, mouse or touch-screen.
- the user can control client device 102 indirectly by interacting with the user interface(s) of server device 104, which in turn interacts with client device 102 across wireless link 103.
- LCD liquid crystal display
- Server device 104 can also communicate with another device 105, such as for sending glucose data from devices 102 and 104 to data storage in device 105, and/or receiving instructions or an insulin pump protocol from a health care provider computer 105. Examples of such communication include a PDA 104 synching data with a personal computer (PC) 105, a mobile phone 104 communicating over a cellular network with a computer 105 at the other end, or a household appliance 104 communicating with a computer system 105 at a physician's office.
- PC personal computer
- the glucose meter housing may contain any glucose sensing system of the type well known in the art that can be configured to fit into a small profile. Such a system can include, for example, the electrochemical glucose strip and meter sensing system sold by TheraSense, Inc. of Alameda, California under the FreeStyle® brand, or other strip and meter glucose measuring systems.
- the housing may thus encompass the sensor electronics and a strip connector, which connector is accessed via a test strip port opening in the housing.
- the housing will typically also include a battery or batteries.
- a redundant test strip interface 301 can be provided if desired for receiving test strips 101.
- Device 104 can be a proprietary unit designed specifically for use with blood glucose meters, or can be a generic, multipurpose device such as a standard PDA.
- An example of a similar device designed for blood glucose testing is disclosed in U.S. Patent No. 6,560,471 issued May 6, 2003 to TheraSense, Inc. entitled “Analyte Monitoring Device and Methods of Use", incorporated herein by reference.
- Figure 4 shows examples of the devices to and from which the meter of the invention can communicate.
- Such devices will become part of an individual's personal area network and each becomes enabled with short range wireless communication capabilities.
- Desktop, laptop and handheld computers, as well as printers can be so enabled and will provide displays and printouts valuable as records for the diabetic.
- Telephones will also be enabled in this fashion and can be used for displaying glucose data as well as further transmitting the data over larger networks.
- Many of these devices can assist the diabetic by responding to glucose levels by providing alarms, or suggesting that action be taken to correct a hypo or hyperglycemic condition, or to call necessary medical assistance.
- Diabetics are aware of the risks involved in driving when glucose levels are out of range and particularly when they are too low.
- the navigation computer in the diabetic's car may become part of the local area network and will download glucose data from the meter when the diabetic enters the car.
- the car computer system may be programmed to require that the diabetic perform a glucose test before driving, and more specifically the car may be disabled unless the diabetic takes the test and the result is in an appropriate range.
- the pen shaped client device 102 shown in Fig. 4 preferably has a test strip port
- the sensitive analog "front end" circuitry associated with measuring the very small electrochemistry currents from test strips 101 is located adjacent strip port 201, it is advisable to not design a wireless link antenna too close to this distal end as it may interfere with the proper operation of the glucose sensing circuitry.
- the wireless link antenna is located at the proximal end of the client device 102, it will likely be covered by the hand of the user holding it, which may limit the range of the low transmission power device to an unacceptable distance. Accordingly, it is preferable to design the layout of client device 102 such that an internal antenna is located in a middle section of the device away from the distal and proximal ends.
- Test strip port 201 can be located in the side of integrated device 102' or wherever there is room available.
- a test strip storage compartment can also be located within integrated device 102' and accessed through a flip-lid 220 or other suitable closure means. If room permits, a second test strip storage compartment (not shown) can be included so that fresh strips and used strips can be separately stored.
- a desiccant is provided in one of the storage compartments to preserve the fresh strips.
- “displayless” glucose meter unit on a separate display device in order to minimize the complexity and cost of the meter unit.
- This permits the user to use the larger display units within his or her personal area network, all of which can be synchronized as they interact and communicate with the wireless enabled meter.
- the sequences through which the user must "step” to complete the test are readily viewed on the larger display units (e.g. entering the calibration code, prompting application of the sample).
- the meter unit is simplified, smaller and less expensive to manufacture.
- control buttons that are found on typical glucose meters can be eliminated, saving additional size and cost, since the user can rely on the user in out features of the server device instead. It is expected that the simplified, wireless enabled meters of the invention may ultimately become inexpensive enough to make them disposable after a specified number of uses, permitting the producer to routinely upgrade as appropriate.
- the system permits the user to include security coding at any time the meter unit accesses a display device, so that the user's data is secure. That is, it is considered an important feature of the invention that when the "client" meter of the invention is used, that the system will require the user to enter an identity code in order to verify that the person handling the meter is indeed an authorized user. Of course, it is possible for the system to permit more than one user if the meter owner so desires. Moreover, the user's data may optionally be encrypted prior to wireless transmission and thereafter respectively decrypted upon wireless reception.
- the module need not include a large or expensive display, it may nevertheless be advantageous to include some ability to advise the user of a glucose level which is determined when the module is used as a "stand-alone" unit.
- the module could include a very low cost, small three digit LCD display.
- the module could include LED indicator lights (e.g. red for out of desired range, green for within desired range).
- LED indicator lights e.g. red for out of desired range, green for within desired range.
- Other possibilities include a red LED for below range, a green LED for within range, and a yellow LED for above range, or a column of LEDs or an electroluminescent strip (similar to those used on common batteries to indicate battery life) to indicate approximate or relative glucose levels.
- FIG. 6 shows a diagram of a health monitor device 600 in accordance with some embodiments of this disclosure.
- the health monitor device 600 may be used for determining a concentration of an analyte in blood or interstitial fluid.
- the health monitor device 600 may be an analyte test meter, such as a glucose test meter that may be used for determining an analyte concentration, such as a blood glucose concentration, of a sample for determination of a blood glucose level of a patient, such as a patient with Type-1 or Type-2 diabetes.
- the health monitor device 600 may be a blood glucose meter, a continuous monitor, an insulin pump, a blood pressure meter, a heart rate monitor, a thermometer, or any other health monitor device capable of measuring, monitoring, or storing raw or analyzed medical data electronically.
- the health monitor device 600 may communicate in a wireless communication system, such as the wireless system shown in Fig. 1.
- the health monitor device 600 may receive fluid samples, or sample data, from a sensor device 602, such as the test strip 101 shown in Fig. 1, and may wirelessly transmit data to an external device 604, such as the server device 104 shown in Fig. 1.
- the health monitor device 600 may include a housing 610, a processor 620, a sensor interface 630, a user interface 640, a clock 650, a data storage unit 660, a power supply 670, and a communication interface 680.
- the housing 610 may physically enclose one or more of the processor 620, the sensor interface 630, the user interface 640, the clock 650, the data storage unit 660, the power supply 670, or the communication interface 680, and may be configured to fit into a small profile.
- the housing 610 is shown a single physical unit, the housing 610 may be implemented as one or more physical units that may be physically or electronically connected.
- the housing 610 may include one or more ports, such as a test strip port, a power port, an audio connection port, or a data connection port.
- the housing 610 may include a test strip port configured to receive a test strip, which may include a fluid sample, and may be connected to the sensor interface 630.
- the processor 620 may include any device capable of manipulating or processing a signal or other information, including an optical processor, a quantum processor, a molecular processor, or a combination thereof.
- the processor 620 may include a general purpose processor, a central processing unit (CPU), a special purpose processor, a plurality of microprocessors, a controller, a microcontroller, an Application Specific Integrated Circuit (ASIC), a Field Programmable Gate Array (FPGA), a programmable logic array, programmable logic controller, microcode, firmware, any type of integrated circuit (IC), a state machine, or any combination thereof.
- ASIC Application Specific Integrated Circuit
- FPGA Field Programmable Gate Array
- microcode firmware, any type of integrated circuit (IC), a state machine, or any combination thereof.
- the term "processor” includes a single processor or multiple processors.
- the processor 620 may be operatively coupled to the sensor interface 630, the user interface 640, the clock 650, the data storage unit 660, the power supply 6
- the sensor interface 630 may receive a fluid sample, such as a fluid sample transported via the test strip 101 shown in Fig. 1, and the processor 620 may control the sensor interface 630 to analyze the fluid sample to determine an associated analyte level.
- the sensor interface 630 may receive raw or analyzed data indicating an analyte level associated with a fluid sample analyzed at an external measurement device, such as a continuous analyte monitoring device, via a wireless communication medium, such as radio frequency identification (RFID).
- RFID radio frequency identification
- the continuous analyte monitoring device may include a transcutaneously implanted sensor, such as an implantable glucose sensor, that may continually or substantially continually measure an analyte concentration of a bodily fluid.
- the sensor interface 630 may receive analyte related data from the external measurement device periodically, based on a transmission schedule, or may request the data from the external measurement device.
- the user interface 640 may include a display unit and one or more input elements, such as buttons, jogs, or dials.
- the user interface 640, or a portion thereof, may be integrated with the housing 610.
- the user interface 640 may form a part of an external surface of the housing 610.
- the user interface 640, or a portion thereof may be configured to allow a user of the health monitor device 600 to receive information, input information, or otherwise interact, with the health monitor device 600.
- the user of the health monitor device 600 may operate the one or more input buttons to enter a calibration code associated with a test strip or other fluid sample reception device.
- the user interface 640 may present visual, tactile, or auditory information indicating, for example, a blood glucose measurement to the user.
- the display unit may include a graphical display unit, such as a LCD or an LED display, an auditory display unit, such as speaker, or both a graphical display and an audio display.
- the user interface 640 may include a touch screen display.
- the display unit, the input elements, or both may be omitted from the user interface 640.
- the clock 650 may be operatively coupled to the processor 620 and may provide a clock signal at discreet clock frequencies to the processor 620.
- the clock may include an oscillator, such as a quartz crystal oscillator, or any other device capable of producing a clock signal for indicating a real time clock.
- the data storage unit 660 may store raw data, analyzed data, or both.
- the data storage unit 660 may store instructions that may be executed by the processor to, for example, perform analysis, such as analyte concentration analysis and medication dosage calculation.
- the data storage unit 660 may include any non-transitory computer-usable or computer-readable medium, such as any tangible device that can, for example, contain, store, communicate, or transport instructions, or any information associated therewith, for use by or in connection with the processor 620.
- the non-transitory computer- usable or computer-readable medium may be, for example, a solid state drive, a memory card, removable media, a read only memory (ROM), a random access memory (RAM), any type of disk including a hard disk, a floppy disk, an optical disk, a magnetic or optical card, an application specific integrated circuits (ASICs), or any type of non-transitory media suitable for storing electronic information, or any combination thereof.
- the data storage unit 660 may be operatively connected to, for example, the processor 620 through, for example, a memory bus.
- the power supply 670 may be any suitable device for powering the health monitor device 600, or any portion thereof.
- the power supply 670 may include a wired power source; one or more dry cell batteries, such as nickel-cadmium (NiCd), nickel-zinc (NiZn), nickel metal hydride (NiMH), lithium-ion (Li-ion); solar cells; fuel cells; or any other device capable of powering the health monitor device 600.
- the processor 620, the sensor interface 630, the user interface 640, the clock 650, the data storage unit 660, or the communication interface 680, may be operatively coupled to the power supply 670.
- the communication interface 680 may communicate with an external device 604, such as the sever 104 shown in Fig. 1 and Fig. 4.
- the communication interface 680 may be an RF transmitter, such as the RF transmitter 206 shown in Fig. 2, and may communicate using a wireless communication protocol, such as an 802.11 protocol, a Bluetooth® RF protocol, a cellular protocol, or any other wireless protocol.
- the communication interface 680 may include a receiver, a transmitter, or a transceiver.
- the communication interface 680 may include a wireless transmission unit, such as a Bluetooth® low energy wireless transmission unit.
- the communication interface 680 may include a wireless antenna, a wired communication port, such as an Ethernet port, an infrared port, a serial port, or any other wired or wireless unit capable of interfacing with a wired or wireless electronic communication medium.
- the health monitor device 600 may communicate with the external device 604 indirectly via another device, or series of devices.
- the health monitor device 600 may communicate with the external device 604 via a network, wherein the health monitor device 600 may transmit signals to, for example, an access point (not shown), and the access point may transmit the signals to the external device 604, in the same or a different format, via one or more other devices in a network.
- the communication interface 680 may communicate with the external device 604 using a low energy wireless communication protocol, such as Bluetooth® low energy. Communicating using a low energy wireless communication protocol may allow the communication interface 680 to use substantially less power than communicating using other wireless communication protocols, such as other versions of Bluetooth®. For example, using a low energy wireless communication protocol, the communication interface 680 may have a lower duty cycle and may actively operate less frequently, for shorter periods of time, or both.
- a low energy wireless communication protocol such as Bluetooth® low energy.
- the processor 610, the communication interface 680, or a combination of the processor 610 and the communication interface 680 may determine whether to use a wireless communication protocol, such as Bluetooth®, or a low energy wireless communication protocol, such as Bluetooth® low energy.
- a wireless communication protocol such as Bluetooth®
- a low energy wireless communication protocol such as Bluetooth® low energy.
- the processor 610 may determine which wireless communication protocol to use based on network conditions, battery conditions, sensed data, or a combination thereof.
- the health monitor device 600 may audibly present information, such as information indicating an analyte concentration, information indicating a rate of change of an analyte concentration, or information indicating the exceeding of a threshold of an analyte concentration, which may indicate, for example, hypo- or hyperglycemia.
- the user interface 640 may include a speaker, and the health monitor device 600 may present the audio signal via the speaker.
- the health monitor device 600 may transmit raw or analyzed analyte information to the external device 604 and the external device 604 may generate an audio signal for presentation.
- the health monitor device 600 may generate an audio signal indicating the information and may transmit the audio indication to the external device 604 for audio presentation.
- the processor 620, the sensor interface 630, the user interface 640, the clock 650, the data storage unit 660, the power supply 670, the communication interface 680, or any combination thereof, may be integrated in one or more electronic units, circuits, or chips.
- Fig. 7 shows an example of wireless communication authentication in accordance with some embodiments of this disclosure.
- a health monitor device such as the health monitor device 600 shown in Fig. 6, may perform wireless communication authentication to establish an authenticated wireless communication link with an external device to transmit an audio indication of health monitoring information, such as analyte information, to the external device.
- Wireless communication authentication may include detecting a sample at 710, analyzing the sample at 720, determining an analyte concentration at 730, storing analyte information at 740, generating an unauthenticated pairing at 750, preventing communication using the pairing at 760, generating an authenticated pairing at 770, transmitting an indication of the analyte concentration at 780, or a combination thereof.
- wireless communication authentication is described with reference to detecting and transmitting analyte information, wireless communication authentication may be used to pair a health monitor device with an external device independently of detecting and transmitting analyte information.
- a sample such as a blood sample
- the health monitor device may include a sensor interface, such as the sensor interface 630 shown in Fig. 6, configured to receive a receive a fluid sample, such as a fluid sample transported via a test strip, such as the test strip 101 shown in Fig. 1.
- the sample may be identified by an external measurement device, such as a continuous analyte monitoring device, configured to communicate with the health monitor device using, for example, a short range wireless communication method, such as RFID.
- the continuous analyte monitoring device may include a transcutaneously implanted sensor that may continually or substantially continually measure an analyte concentration of a bodily fluid.
- the sample may be analyzed to determine a corresponding analyte level, such as a glucose level, at 720.
- the health monitor device may include a processor, such as the processor 620 shown in Fig. 6, configured to analyze the sample.
- the sample may be analyzed by an external analysis device, such as a continuous analyte monitoring device, configured to communicate with the health monitor device.
- An analyte concentration may be identified at 730.
- the analyte concentration may be identified based on the sample analysis at 720.
- the analyte concentration may be received from an external analysis device, such as a continuous analyte monitoring device, configured to communicate with the health monitor device.
- the analyte concentration may be identified based on stored information, such as previously stored raw or analyzed sample data.
- raw or analyzed analyte information such the analyte concentration identified at 730
- health monitor device may include a data storage unit, such as the memory 660 shown in Fig. 6, a processor, such as the processor 620 shown in Fig. 6, a sensor interface, such as the sensor interface 630 shown in Fig. 6, or a combination thereof, and the processor, the sensor interface, or a combination thereof, may identify the analyte concentration based on raw or analyzed analyte data stored on the data storage unit.
- An unauthenticated wireless communications pairing may be generated at 750. Generating the unauthenticated wireless communications pairing may include performing a wireless protocol stack pairing procedure at 752, suppressing a pairing message at 754, completing the pairing procedure at 756, or a combination thereof.
- a wireless protocol stack pairing, or bonding, procedure may be performed at 752 to establish a relationship (bond or pairing) between the health monitor device and the external device.
- the wireless protocol stack pairing procedure may be omitted if the health monitor device previously established an authenticated communication link with the external device.
- Performing the wireless protocol stack pairing procedure may include generating a shared secret key (link key) at the health monitor device and the external device.
- the wireless protocol stack pairing procedure may include displaying a pairing message at the health monitor device, the external device, or both.
- the wireless protocol stack pairing procedure may request user input of a pin code or passkey, such as an alphanumeric string. Implementations of the pairing message may vary among devices, which may cause the wireless protocol stack pairing procedure to fail, or may make the wireless protocol stack pairing procedure difficult for users to understand.
- the pairing message may be suppressed at 754.
- the wireless protocol stack pairing procedure may be a Bluetooth® pairing procedure and the pairing message may include one or more Bluetooth® pairing confirmation messages.
- the wireless protocol stack pairing procedure may not include pairing messages and suppressing the complex pairing message may be omitted.
- the wireless protocol stack pairing procedure may be a simplified Bluetooth® pairing procedure that does request user input and suppressing the pairing procedure may be omitted.
- the wireless protocol stack pairing procedure may be completed at 756.
- Completing the wireless protocol stack pairing procedure may include storing an unauthenticated wireless protocol bond or pairing.
- the health monitor device, the external device, or both may store an indication of the unauthenticated wireless protocol bond.
- communication of health related information between the health monitor device and the external device may be prevented at 760.
- communication may be prevented where a wireless protocol bond (pairing) does not exist, or where an established wireless protocol bond is an unauthenticated pairing.
- An authenticated pairing may be generated at 760. Generating an authenticated pairing may include performing a pairing authentication procedure at 772, converting the unauthenticated pairing to an authenticated pairing at 774, or a combination thereof.
- Performing the pairing authentication procedure at 772 may include performing an application layer authentication, which may include displaying authentication information at the health monitor device, the external device, or both.
- a user may confirm the authentication at the health monitor device, the external device, or both, and the unauthenticated pairing may be converted to an authenticated pairing at 774.
- confirming the authentication may include requesting user input at the health monitor device, the external device, or both, to authenticate the wireless communication protocol bond between the health monitor device and the external device.
- User input authenticating the wireless protocol bond may be received at the health monitor device, the external device, or both.
- converting the unauthenticated pairing to an authenticated pairing may include storing an indication that the wireless protocol bond is authenticated, or removing an indication that the wireless protocol bond is not authenticated, at the health monitor device, the external device, or both.
- the authentication information may include a short alphanumeric string, such a four or six character string.
- the authentication information may include, a name, or part of a name, associated with the health monitor device or the external device, such as a name of a user logged in on the external device, or a name of the device.
- the authentication information may include an identifier, or part of an identifier, associated with the device, such as a serial number of the health monitor device, or part of a GUID associated with the external device.
- the authentication information may include a phone number, associated with one or both of the devices.
- the authentication information may include a random or pseudorandom string.
- the external device may generate an authentication string, and may transmit the string to the health monitor device.
- the health monitor device may generate the authentication string and may transmit the string to the external device.
- a user may confirm the authentication string at the health monitor device, the external device, or both.
- the authentication string may be displayed at the health monitor device and the external device, and the user may confirm the authentication, or reject the authentication, based on a comparison of the authentication string displayed at each device.
- the authentication information may include an image.
- an image may be a diagram of a simple object, such as a circle, a star, or a square; an image may be a photograph, such as a photograph of a user of the external device; or an image may be any other graphical element capable of reasonably authenticating the pairing.
- image may be an indication of an image, such as an index of a randomly or pseduorandomly selected image from a shared source of images, such as a shared table or database of images. A user may confirm or reject the authentication based on a comparison of the authentication image displayed at each device.
- the health monitor device may randomly or pseudorandomly select an authentication image and may send the authentication image, or an indication of the authentication image, to the external device.
- the external device may randomly or pseudorandomly select an authentication image and may send the authentication image, or an indication of the authentication image, to the health monitor device.
- An indication of the analyte concentration may be transmitted at 780.
- the indication of the analyte concentration may be transmitted from the health monitor device to the external device using, for example, a Bluetooth® link established based on the bond established at 750 and authenticated at 770.
- transmitting the indication of the analyte concentration may include transmitting raw or analyzed analyte information.
- transmitting the indication of the analyte concentration may include transmitting health care instructions.
- transmitting the indication of the analyte concentration may include synchronizing information between the health monitor device and the external device.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- General Business, Economics & Management (AREA)
- Chemical & Material Sciences (AREA)
- Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Human Computer Interaction (AREA)
- Biochemistry (AREA)
- Databases & Information Systems (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Software Systems (AREA)
- Computer Security & Cryptography (AREA)
- Theoretical Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Computer Hardware Design (AREA)
- Computer Networks & Wireless Communication (AREA)
- Signal Processing (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/665,234 US20130059541A1 (en) | 2003-06-10 | 2012-10-31 | Wireless Communication Authentication for Medical Monitoring Device |
PCT/US2013/065469 WO2014070471A1 (en) | 2012-10-31 | 2013-10-17 | Wireless communication authentication for medical monitoring device |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2915129A1 true EP2915129A1 (en) | 2015-09-09 |
EP2915129A4 EP2915129A4 (en) | 2016-04-06 |
Family
ID=50627942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13852024.2A Withdrawn EP2915129A4 (en) | 2012-10-31 | 2013-10-17 | Wireless communication authentication for medical monitoring device |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2915129A4 (en) |
WO (1) | WO2014070471A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10722631B2 (en) | 2018-02-01 | 2020-07-28 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
US11185677B2 (en) | 2017-06-07 | 2021-11-30 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
US11724089B2 (en) | 2019-09-25 | 2023-08-15 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
US11964145B2 (en) | 2019-07-12 | 2024-04-23 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of manufacture and use |
US12102815B2 (en) | 2019-09-25 | 2024-10-01 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible pump housings |
US12121713B2 (en) | 2019-09-25 | 2024-10-22 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible blood conduits |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4418712A3 (en) | 2014-05-21 | 2024-10-02 | Abbott Diabetes Care, Inc. | Management of multiple devices within an analyte monitoring environment |
US10237389B2 (en) * | 2016-07-20 | 2019-03-19 | Dexcom, Inc. | System and method for wireless communication of glucose data |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130059541A1 (en) * | 2003-06-10 | 2013-03-07 | Abbott Diabetes Care Inc. | Wireless Communication Authentication for Medical Monitoring Device |
EP1635508A1 (en) | 2004-09-08 | 2006-03-15 | Koninklijke Philips Electronics N.V. | Secure pairing for wireless communications devices |
KR100782083B1 (en) | 2006-10-11 | 2007-12-04 | 삼성전자주식회사 | Audio play system of potable device and operation method using the same |
US8131566B2 (en) | 2006-10-24 | 2012-03-06 | Medapps, Inc. | System for facility management of medical data and patient interface |
US9060267B2 (en) | 2006-12-29 | 2015-06-16 | Belkin International, Inc. | Secure pairing of networked devices |
US8768251B2 (en) | 2007-05-17 | 2014-07-01 | Abbott Medical Optics Inc. | Exclusive pairing technique for Bluetooth compliant medical devices |
EP2001188A1 (en) | 2007-06-08 | 2008-12-10 | F.Hoffmann-La Roche Ag | Method for authenticating a medical device and a remote device |
WO2009005950A2 (en) | 2007-06-29 | 2009-01-08 | Roche Diagnostics Gmbh | Device and methods for optimizing communications between a medical device and a remote electronic device |
US20110217950A1 (en) | 2010-03-05 | 2011-09-08 | Alan Kozlay | Apparatus & method to improve pairing security in Bluetooth™ headsets & earbuds |
US8907782B2 (en) * | 2010-06-30 | 2014-12-09 | Welch Allyn, Inc. | Medical devices with proximity detection |
-
2013
- 2013-10-17 EP EP13852024.2A patent/EP2915129A4/en not_active Withdrawn
- 2013-10-17 WO PCT/US2013/065469 patent/WO2014070471A1/en active Application Filing
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11185677B2 (en) | 2017-06-07 | 2021-11-30 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11717670B2 (en) | 2017-06-07 | 2023-08-08 | Shifamed Holdings, LLP | Intravascular fluid movement devices, systems, and methods of use |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US10722631B2 (en) | 2018-02-01 | 2020-07-28 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
US11229784B2 (en) | 2018-02-01 | 2022-01-25 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
US12076545B2 (en) | 2018-02-01 | 2024-09-03 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
US11964145B2 (en) | 2019-07-12 | 2024-04-23 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of manufacture and use |
US11654275B2 (en) | 2019-07-22 | 2023-05-23 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
US11724089B2 (en) | 2019-09-25 | 2023-08-15 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
US12102815B2 (en) | 2019-09-25 | 2024-10-01 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible pump housings |
US12121713B2 (en) | 2019-09-25 | 2024-10-22 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible blood conduits |
Also Published As
Publication number | Publication date |
---|---|
EP2915129A4 (en) | 2016-04-06 |
WO2014070471A1 (en) | 2014-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20130059541A1 (en) | Wireless Communication Authentication for Medical Monitoring Device | |
US10290208B2 (en) | Methods for enabling a disabled capability of a medical device | |
US20200163549A1 (en) | Glucose Measuring Device for Use in Personal Area Network | |
US20140118104A1 (en) | Low Energy Communication of Medical Monitoring Information | |
EP2915129A1 (en) | Wireless communication authentication for medical monitoring device | |
US11783941B2 (en) | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof | |
JP6977016B2 (en) | Remote monitoring of sample measurement | |
EP2146622B1 (en) | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device | |
US20110015502A1 (en) | Analyte Monitoring and Management System and Methods Therefor | |
US20120330555A1 (en) | Analyte Testing System with Docking Station for Data Management | |
WO2019008296A1 (en) | Device for measuring physiological parameters of a human or animal individual | |
EP3399904A1 (en) | Device for obtaining at least one physiological parameter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150528 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20160308 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G06F 19/00 20110101ALI20160302BHEP Ipc: G06F 21/44 20130101ALI20160302BHEP Ipc: G06Q 50/22 20120101AFI20160302BHEP Ipc: H04W 12/06 20090101ALI20160302BHEP Ipc: H04B 5/00 20060101ALI20160302BHEP Ipc: G01N 33/487 20060101ALI20160302BHEP |
|
17Q | First examination report despatched |
Effective date: 20171009 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20190426 |